 Anticuerpos monoclonales como dianas de los tumores EGFR+ |
 |
Herbst RS, Shin DM
Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy.
Cancer 2002 Mar 1;94(5):1593-611
|
|
| |
| Inhibidores de la transducción de la señal en el cáncer de pulmón |
|
Arteaga CL, Khuri F, Krystal G, Sebti S
Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer.
Semin Oncol 2002 Feb;29(1 Suppl 4):15-26
|
|
| |
| Papel del EGFR en el cáncer de pulmón y en la premalignidad |
|
Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr
Epidermal growth factor receptor family in lung cancer and premalignancy.
Semin Oncol 2002 Feb;29(1 Suppl 4):3-14
|
|
| |
| Inhibidores de la angiogénesis durante el desarrollo del cáncer de pulmón |
|
Herbst RS, Hidalgo M, Pierson AS, Holden SN, Bergen M, Eckhardt SG
Angiogenesis inhibitors in clinical development for lung cancer.
Semin Oncol 2002 Feb;29(1 Suppl 4):66-77
|
|
| |
| Familia ErbB de los receptores de las tirosín quinasas como blancos moleculares |
|
Slichenmyer WJ, Fry DW
Anticancer therapy targeting the erbB family of receptor tyrosine kinases.
Semin Oncol 2001 Oct;28(5 Suppl 16):67-79
|
|
| |
| HER2 como blanco molecular: esperanzas y realidades |
|
Leyland-Jones B
Trastuzumab: hopes and realities.
Lancet Oncol 2002 Mar;3(3):137-44
|
|
| |
| Factores de crecimento: nuevas dianas para el cáncer de próstata |
|
Barton J, Blackledge G, Wakeling A
Growth factors and their receptors: new targets for prostate cancer therapy.
Urology 2001 Aug;58(2 Suppl 1):114-22
|
|
| |
| STI571: un inhibidor TK BCR-ABL para el tratamiento de la LMC |
|
O'Dwyer ME, Druker BJ
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia.
Lancet Oncol 2000 Dec;1:207-11
|
|
| |
| Inhibición de la actividad tirosín quinasa KIT |
|
Heinrich MC, Blanke CD, Druker BJ, Corless CL
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies.
J Clin Oncol 2002 Mar 15;20(6):1692-703
|
|
| |
| Inhibidores de la farnesil transferasa: nuevas dianas moleculares en el tratamiento del cáncer |
|
Johnston SR
Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer.
Lancet Oncol 2001 Jan;2(1):18-26
|